The Global clinical trial patient recruitment services market is projected to grow from $ 0.84 Bn in 2022 to $1.56 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-30. The Global clinical trial patient recruitment services market is a rapidly growing market that provides services to support the recruitment of patients for clinical trials. Some key players in the global clinical trial patient recruitment services market include IQVIA, Parexel International, PRA Health Sciences, Syneos Health, and WCG Clinical. Other important players include ICON plc, Medpace, Charles River Laboratories, and Premier Research.
The Global Cholangiocarcinoma market is expected to witness growth as the incidence of Cholangiocarcinoma is rising globally. The market is segmented by treatments, distribution channels, and regions. Incyte Corporation and Eisai are the key players in the Global Cholangiocarcinoma market.
This report presents a strategic analysis of the Global Dental Care Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Global Dental Care Market, offering unmatched value, accuracy and expert insights.
The Global Health Economics and Outcomes Research (HEOR) Services Market is projected to grow from $1.5 Bn in 2022 to $3.6 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-2030. The market under study is anticipated to be dominated by North America. Factors such as increasing research and development expenditure by biotechnology and pharmaceutical companies across the countries in the region and booming clinical trials coupled with drug approvals, especially in the United States, are driving the growth of the HEOR services market in North America.
The growing adoption of lasers in dermatology is leading to superior results and is responsible for the growth of the Global aesthetic devices market during the forecast period. The market is segmented by product, application, end user, and by region. Alma Lasers and Lumenis are the major players in the Global aesthetic devices market.
The Global apheresis market is projected to grow from $3.6 Mn in 2022 to $6.4 Mn in 2030 with a CAGR of 8% for the year 2022-2030. Growth of the market will be mainly driven by the rising prevalence of chronic diseases and a growing number of trauma and injury cases. Fresenius Kabi and Terumo are key players in the market.
The Global ADHD market is projected to grow from $29.56 Bn in 2022 to $52.72 Bn in 2030 with a CAGR of 7.5% for the year 2022-2030. The increase in diagnosis and treatment options for ADHD are the main market drivers. The market is segmented by drug class, drug type, distribution channel, and by geographic region.
The Global digital therapeutics market is projected to grow as trends toward mhealth and other digital technologies for healthcare continue. The market is segmented by application, product type, technologies, and by region. Omada Health and Virta Health are some of the major players in the market.
The Global gram-negative infections therapeutics market is projected to grow during the forecast period as the rate of antibiotic resistant strains continue to increase. Major gram-negative infections include pneumonia and bloodstream infections. The market is segmented by infection, treatment, and by region.
The introduction of new therapeutic options for the acute phase of NMOSD presents a potential opportunity for the growth of the Global NMOSD drugs market. The market is segmented by drug therapy, application, distribution channel, and by region. Novartis and Pfizer are the key players in the market.
Glaucoma and dry eye are the most common eye disorders affecting the population globally, hence the demand for Over The Counter (OTC) drugs is on the rise thereby leading to the growth of the Global OTC ophthalmic drugs market. The market is segmented by indication and by dosage form.
Global Patient Support Programs (PSP) market is projected to grow during the forecast period as a result of more pharma companies investing in these programs and due to the rise in the demand for personalized medicine. Connect 360 by AstraZeneca and Assist 360 by Amgen are some of the top pharma-sponsored PSP programs.